ProfileGDS4718 / 212766_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 90% 88% 89% 90% 88% 93% 93% 90% 89% 88% 90% 89% 93% 94% 92% 89% 89% 92% 94% 89% 89% 91% 89% 90% 90% 95% 90% 92% 90% 96% 91% 92% 89% 91% 92% 95% 94% 91% 91% 91% 90% 92% 89% 95% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.2803390
GSM549102patient 115, normal, homogenized [OPG study]8.8606588
GSM549104patient 119, normal, homogenized [OPG study]9.0733789
GSM549108patient 138, normal, homogenized [OPG study]9.054790
GSM549119patient 077, normal, homogenized [OPG study]8.8995788
GSM549133patient 032, cancer, homogenized [OPG study]9.8937593
GSM549139patient 042, cancer, homogenized [OPG study]9.7569593
GSM549099patient 107, normal, homogenized [OPG study]9.2278890
GSM549109patient 139, normal, homogenized [OPG study]9.0474789
GSM549110patient 046, normal, homogenized [OPG study]8.870688
GSM549114patient 063, normal, homogenized [OPG study]9.2784890
GSM549122patient 082, normal, homogenized [OPG study]9.0469889
GSM549134patient 033, cancer, homogenized [OPG study]9.6507493
GSM549136patient 036, cancer, homogenized [OPG study]10.045294
GSM549140patient 044, cancer, homogenized [OPG study]9.4842492
GSM549111patient 047, normal, homogenized [OPG study]9.1741889
GSM549113patient 057, normal, homogenized [OPG study]9.2059789
GSM549132patient 031, cancer, homogenized [OPG study]9.4148592
GSM549137patient 038, cancer, homogenized [OPG study]9.8033294
GSM549142patient 047, cancer, homogenized [OPG study]8.5494689
GSM549100patient 110, normal, homogenized [OPG study]8.9485889
GSM549107patient 135, normal, homogenized [OPG study]9.3857291
GSM549115patient 068, normal, homogenized [OPG study]9.1650289
GSM549116patient 072, normal, homogenized [OPG study]9.2164990
GSM549120patient 078, normal, homogenized [OPG study]9.2396190
GSM549131patient 030, cancer, homogenized [OPG study]10.156395
GSM549118patient 074, normal, homogenized [OPG study]9.1970190
GSM549129patient 027, cancer, homogenized [OPG study]9.3411692
GSM549123patient 088, normal, homogenized [OPG study]9.1796190
GSM549124patient 006, cancer, homogenized [OPG study]10.220896
GSM549126patient 015, cancer, homogenized [OPG study]9.39191
GSM549128patient 025, cancer, homogenized [OPG study]9.6019592
GSM549103patient 117, normal, homogenized [OPG study]9.0152789
GSM549117patient 073, normal, homogenized [OPG study]9.5039291
GSM549138patient 041, cancer, homogenized [OPG study]9.4882592
GSM549141patient 045, cancer, homogenized [OPG study]10.269295
GSM549130patient 028, cancer, homogenized [OPG study]9.7817494
GSM549101patient 111, normal, homogenized [OPG study]9.2700991
GSM549105patient 128, normal, homogenized [OPG study]9.3958191
GSM549106patient 134, normal, homogenized [OPG study]9.5194391
GSM549112patient 048, normal, homogenized [OPG study]9.2892690
GSM549125patient 011, cancer, homogenized [OPG study]9.5449192
GSM549127patient 024, cancer, homogenized [OPG study]8.9405489
GSM549135patient 035, cancer, homogenized [OPG study]10.26495